Could cause temporary or reversible harm; serious harm is unlikely.
Failed Dissolution Specifications
| Brand name | EXTENDED PHENYTOIN SODIUM |
| Generic name | PHENYTOIN SODIUM |
| Active ingredient(s) | PHENYTOIN SODIUM |
| Distributed by / for | Amneal Pharmaceuticals LLC Bridgewater, NJ, 08807 |
| NDC | 65162-212-10 |
| Full product label | Extended Phenytoin Sodium Capsules, USP, 100 mg, 100-count bottle, Distributed by Amneal Pharmaceuticals LLC Bridgewater, NJ, 08807, NDC# 65162-212-10 |
| Recalling firm | Amneal Pharmaceuticals of New York, LLC |
| Distribution | Nationwide in the USA and Puerto Rico |
| Quantity | 9,263 100-count bottles |
| Recall initiated | 2023-10-27 |
| Report date | 2023-11-15 |
| Recall completed | 2025-08-06 |
| Recall number | D-0090-2024 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Brookhaven NY United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗